Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BIIB

Robust demand, technological advancements, government and private investment, are fueling the biotech industry’s expansion and driving game-changing therapies and product development. With the industry anticipated to thrive, fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and United Therapeutics (UTHR) look poised for substantial gains. Keep reading.

StockNews.com

3 Biotech Stocks Smart Money Is After

Biotech companies such as Biogen (BIIB), Cidara Therapeutics (CDTX), and Theratechnologies (THTX) with the interest of institutional investors could be worth investing in now. Continue reading….

StockNews.com

3 Biotech Stocks to Acquire in July

With the surge in new drug formulations, the growing prominence of personalized medicine, and favorable government initiatives, the biotech industry is set for significant growth this year and beyond. Thus, it could be wise to invest in fundamentally sound biotech stocks Biogen (BIIB), Alkermes (ALKS), and Theratechnologies (THTX) this month.…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks to Own as Alzheimer's Drugs Bring Relief

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

StockNews.com

3 Biotech Stocks With Some Major Value in Them

The worldwide need for healthcare and biotech products is experiencing a steady upsurge fueled by various factors, such as a heightened emphasis on personalized medicine. Therefore, it could be wise to explore three quality biotech stocks, Gilead Sciences (GILD), Biogen (BIIB), and Alkermes (ALKS), with significant value in them. Read…

StockNews.com

3 Biotech Stocks Every Investor Wants

Given inelastic demand, rapid breakthroughs, and government initiatives, the biotech industry looks well-positioned to thrive. So, quality biotech stocks Gilead Sciences (GILD), Biogen (BIIB), and Alkermes (ALKS) could be worth owning. Read on.

StockNews.com

3 Stocks Poised for Price Surges

Resurging concerns about the Fed’s hawkish stance to tame stubbornly high inflation and recessionary fears have weighed heavily on investors’ sentiments. Therefore, it could be wise to own fundamentally strong stocks Biogen (BIIB), Celestica (CLS), and Biglari Holdings (BH) that look poised to maintain their momentum. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks to Buy Now

The biotech industry is well-positioned to grow, given the inelastic demand, rapid advancements, and government initiatives. So, quality biotech stocks Biogen (BIIB), Alkermes (ALKS), and Vanda (VNDA) could be worth owning. Read on.

StockNews.com

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com

4 Biotech Stocks You Don’t Want to Miss out on in 2023

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading.

StockNews.com

2 Top Biotech Stocks to Buy in March

The biotech industry is expected to witness solid growth amid impressive advancements and government initiatives. Moreover, the biotech sector tends to be more defensive than others during market downturns. So, fundamentally sound biotech stocks Amgen (AMGN) and Biogen (BIIB) might be ideal buys now. Keep reading.

StockNews.com

3 Biotech Stocks With Potential to Be Big Winners in 2023

The biotech industry is well-positioned to grow strongly, given the ever-rising demand for therapies and favorable government initiatives. Looking at the industry’s long-term prospects, fundamentally strong biotech stocks Amgen (AMGN), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) could emerge as big winners this year. Keep reading….

StockNews.com

3 Biotech Stocks to Buy and Hold for the Next 20 Years

The biotech industry is well-positioned for long-term growth owing to strong demand and continued breakthroughs. Furthermore, favorable government funding should boost the industry’s growth. Hence, it could be wise to buy and hold fundamentally sound biotech stocks Amgen (AMGN), Biogen (BIIB), and Amicus Therapeutics (FOLD) for the next two decades.…

StockNews.com

3 No-Brainer Stocks to Buy Right Now Without Hesitation

Cooling inflation data and Fed’s recent 25 bps rate hike have contributed considerably to optimistic investor sentiment in the past few weeks. However, as opposed to an expected pause, the robust jobs report has raised prospects of further rate hikes in the coming months. Therefore, it could be wise to…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Get Bullish on Now

The Fed’s recent 25 bps rate hike in response to cooling inflation and Powell’s dovish comments improved investor sentiment. Amid growing optimism over the slowing interest rate hikes, we think fundamentally strong stocks Archer-Daniels-Midland (ADM), Biogen (BIIB), and MasterCraft (MCFT) are ideal additions to one’s portfolio. Read on….

StockNews.com

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com

3 Top-Rated Stocks to Buy for the Long Haul

Amid economic turmoil and recessionary fears, market volatility is anticipated to continue. However, this could be an opportune time for investors to scoop up quality top-rated stocks Gilead Sciences (GILD), Biogen (BIIB), and AudioCodes (AUDC) for the long haul. Read on….

StockNews.com

Sitting on Cash? These 3 Stocks Are Great Buys Right Now

The U.S. economy is gripped by fears of an economic slowdown due to several macroeconomic and geopolitical headwinds. However, the uncertain market conditions have created opportunities for investors sitting on cash to buy quality stocks at attractive prices. Biogen (BIIB), AutoNation (AN), and AdvanSix (ASIX), which are trading at discounts…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Nasdaq Stocks You'll Regret Not Buying This Year

Although macroeconomic headwinds kept the stock market under immense pressure last year, the declining inflation rates have increased investor optimism recently. Hence, quality Nasdaq stocks Comcast Corporation (CMCSA), Honeywell International (HON), and Biogen (BIIB) might be solid buys this year. Read on….

StockNews.com

3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal additions to your portfolio as they look well-positioned to capitalize…

StockNews.com

3 Value Stocks Worth Your Attention in 2023

With the Fed slated to increase rates aggressively this year to curb inflation, value stocks could shine again. Thus, investors could invest in shares of fundamentally strong stocks Biogen (BIIB), Dow Inc. (DOW), and Albertsons Companies (ACI) that are trading at attractive valuations. Continue reading….

StockNews.com

3 Stocks to Buy Like There's No Tomorrow

While inflation eased considerably for two consecutive months, the Fed signaled to keep raising interest rates through this year. The potential continuation of rate hikes has fueled recessionary concerns. Amid an uncertain macroeconomic backdrop, it could be wise to buy fundamentally strong stocks Merck (MRK), Biogen (BIIB), and MasterCraft Boat…

StockNews.com

4 Warren Buffett Stocks to Buy and Never Sell

Legendary investor Warren Buffett’s holding company Berkshire Hathaway has outperformed the broader market over the past year. His investment portfolio has been a guide for several long-term investors for decades. Amid a highly uncertain market and economic backdrop, Warren Buffett holdings Procter & Gamble (PG), AbbVie (ABBV), Biogen (BIIB), and…

StockNews.com

2 Biotech Stock to Buy Over Moderna This December

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA’s growth, the industry prospects look bright. Therefore, investors looking to invest in biotech stocks could consider buying Biogen (BIIB) and Jazz…

StockNews.com

3 Biotech Stocks to Help You Build a Healthy Portfolio

Biotech industry played a vital role amid the pandemic and continues to witness solid demand amid rising medical needs and chronic diseases. Investor sentiment toward biotech stocks is robust. As biotech is considered a defensive sector against market downturns, investors might buy quality biotech stocks Gilead Sciences (GILD), Biogen (BIIB),…

1 2 3 4 5

People

Mangeet Kaur BounsMangeet

595 stories

Steve Reitmeister

508 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.